IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 105 filers reported holding IMMUNOCORE HLDGS PLC in Q4 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,942,304 | -13.4% | 576,923 | 0.0% | 35.70% | +29.7% |
| Q2 2023 | $34,592,303 | +21.3% | 576,923 | 0.0% | 27.53% | +9.3% |
| Q1 2023 | $28,523,073 | -13.4% | 576,923 | 0.0% | 25.19% | -0.7% |
| Q4 2022 | $32,924,996 | +21.5% | 576,923 | 0.0% | 25.37% | +18.4% |
| Q3 2022 | $27,100,000 | +26.0% | 576,923 | 0.0% | 21.42% | +29.6% |
| Q2 2022 | $21,500,000 | +25.0% | 576,923 | 0.0% | 16.53% | +78.7% |
| Q1 2022 | $17,200,000 | -69.2% | 576,923 | 0.0% | 9.25% | -45.4% |
| Q4 2021 | $55,800,000 | +160.7% | 576,923 | 0.0% | 16.93% | +170.2% |
| Q3 2021 | $21,400,000 | -7.0% | 576,923 | 0.0% | 6.26% | +77.3% |
| Q2 2021 | $23,000,000 | -6.4% | 576,923 | 0.0% | 3.53% | -12.1% |
| Q1 2021 | $24,560,000 | – | 576,923 | – | 4.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $34,592,303 | 27.53% |
| RTW INVESTMENTS, LP | 6,029,633 | $361,536,795 | 6.88% |
| Paradigm Biocapital Advisors LP | 1,270,124 | $76,156,635 | 5.88% |
| Rock Springs Capital Management LP | 3,028,410 | $181,583,464 | 4.32% |
| Logos Global Management LP | 500,000 | $29,980,000 | 4.08% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $24,319,776 | 3.58% |
| GREAT POINT PARTNERS LLC | 297,082 | $17,813,037 | 3.49% |
| Eschler Asset Management LLP | 34,000 | $2,038,640 | 2.89% |
| COWEN AND COMPANY, LLC | 460,036 | $27,583,758 | 2.29% |
| HighVista Strategies LLC | 44,094 | $2,643,876 | 1.21% |